bearish
Biosimilar Battlefield: Unpacking Celltrion
532 Views28 Feb 2019 11:30
Both Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) have reported preliminary 2018 results with some MD&A. As suspected, Q4's...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
- Celltrion Merger: Is It for Real This Time? Why Next Year?16 Jan 2020
- Celltrion Bullish off of Cycle Low with Base Risk Tactics20 Jun 2019
- Celltrion Cycle Low Synergies30 Apr 2019
- Biosimilar Battlefield: Unpacking Celltrion28 Feb 2019
- Celltrion Healthcare: Well, We Were Warned24 Feb 2019
- Biosimilar Battlefield: The Remsima/Inflectra Warning06 Feb 2019
- Biosimilar Battlefield Update: It's Getting Uglier28 Nov 2018
x